Amha Biopharma

Amha Biopharma is a biopharmaceutical company based in Hyderabad, India, dedicated to the development and manufacturing of biosimilars and complex generic injectables. The company focuses on high-demand therapeutic areas including bone health, metabolic disorders, and oncology. Its pipeline features biosimilar versions of blockbuster drugs such as Teriparatide, Liraglutide, and Semaglutide. By utilizing advanced recombinant DNA technology and peptide synthesis, Amha Biopharma aims to provide affordable and accessible biologic treatments to global markets. The firm is led by experienced industry professionals with a focus on rigorous clinical standards and regulatory compliance. Amha Biopharma operates state-of-the-art R&D and manufacturing facilities designed to meet international quality standards.